No Data
What Analysts Are Saying About WAVE Life Sciences Stock
During the last three months, 4 analysts shared their evaluations of WAVE Life Sciences (NASDAQ:WVE), revealing diverse outlooks from bullish to bearish.The following table provides a quick overview o
A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $11 to $19
On Jun 26, major Wall Street analysts update their ratings for $Wave Life Sciences(WVE.US)$, with price targets ranging from $11 to $19.Wells Fargo analyst Tiago Fauth maintains with a buy rating, and
HC Wainwright & Co. Reiterates Buy on WAVE Life Sciences, Maintains $15 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates WAVE Life Sciences (NASDAQ:WVE) with a Buy and maintains $15 price target.
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.2% on Wednesday.Shares of Worthington Enterprises, Inc. (NYSE:WOR) fell sharply in today's pre-market trading after
Update: WAVE Life Sciences Discloses 'Positive' Phase 1b/2a Data From Huntington's Disease Treatment But Shares Fall on Neurofilament Concern
(Updates with the stock move and analyst comments in the fifth, sixth, and seventh paragraphs.) WAVE Life Sciences (WVE) said Tuesday it has seen "positive" results from a Phase 1b/2a trial of WVE-003
Express News | Wave Life Sciences Ltd : Leerink Partners Raises Target Price to $16 From $12